The landscape of human epidermal growth factor receptor 2 (HER2) expression in gynecologic tumors (GTs)

被引：0
|
作者：
Duran, C. Garcia [1 ]
Musacchio, L. [2 ]
Mazzeo, R. [3 ]
Carita, L. [4 ]
Jimenez, J. [5 ]
Bejar, J. F. Grau [6 ]
Illescas, D. G. [7 ]
Fasani, R. [8 ]
Madrid, L. Farinas [1 ]
Villacampa, G. [9 ]
Oaknin, A. [7 ]
机构：
[1] Vall dHebron Inst Oncol, Med Oncol Dept, Barcelona, Spain
[2] Fdn Policlin Univ Agostino Gemelli IRCC, Gynecol Oncol Unit, Rome, Italy
[3] Univ Udine, Med Oncol, Dipartimento Area Med DAME, Udine, Italy
[4] VHIO Valle Hebron Inst Oncol, Oncol Data Sci, Barcelona, Spain
[5] Vall dHebron Inst Oncol, Pathol Anat, Barcelona, Spain
[6] Vall dHebron Inst Oncol, Med Oncol Serv, Barcelona, Spain
[7] Vall dHebron Barcelona Hosp Campus, Vall dHebron Inst Oncol, Med Oncol Serv, Barcelona, Spain
[8] Barcelona Vall dHebron Inst Oncol VHIO, Cellex Ctr, Barcelona, Spain
[9] Vall dHebron Inst Oncol, Stat Dept, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.2150
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
790P
引用
收藏
页码：S590 / S591
页数：2
相关论文
共 50 条
  • [21] Cardiotoxicity From Human Epidermal Growth Factor Receptor-2 (HER2) Targeted Therapies
    Florido, Roberta
    Smith, Karen L.
    Cuomo, Kimberly K.
    Russell, Stuart D.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2017, 6 (09):
  • [22] Circulating human epidermal growth factor receptor 2 (HER2) is associated with hyperglycaemia and insulin resistance
    Memon, Ashfaque A.
    Bennet, Louise
    Zoller, Bengt
    Wang, Xiao
    Palmer, Karolina
    Sundquist, Kristina
    Sundquist, Jan
    JOURNAL OF DIABETES, 2015, 7 (03) : 369 - 377
  • [23] Human epidermal growth factor receptor 2 (HER2) immunoreactivity: specificity of three pharmacodiagnostic antibodies
    Schrohl, Anne-Sofie
    Pedersen, Hans Christian
    Jensen, Sussie Steen
    Nielsen, Signe Lykke
    Bruenner, Nils
    HISTOPATHOLOGY, 2011, 59 (05) : 975 - 983
  • [24] Human epidermal growth factor receptor 2 (HER2) in gastric cancer: a new therapeutic target
    De Vita, F.
    Giuliani, F.
    Silvestris, N.
    Catalano, G.
    Ciardiello, F.
    Orditura, M.
    CANCER TREATMENT REVIEWS, 2010, 36 : S11 - S15
  • [25] Clinical impact of epidermal growth factor receptor (EGFR) coexpression in early breast cancer with human epidermal growth factor receptor 2 (HER2) overexpression
    Park, S.
    Cho, E.
    Shin, Y.
    Hong, S.
    Lee, M.
    Park, Y.
    Nam, S.
    Yang, J.
    Choi, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [26] Draft recommendations for human epidermal growth factor receptor 2 (HER2) testing in breast cancer will decrease HER2 positivity rates
    Johnson, Eric
    Gulbahce, Evin
    CANCER RESEARCH, 2018, 78 (04)
  • [27] Expression of epidermal growth factor receptor and HER2 in sporadic primary small intestinal adenocarcinoma
    Chen, Z. E.
    Perry, A.
    Lin, F.
    Hui, P.
    Wang, H. L.
    MODERN PATHOLOGY, 2007, 20 : 110A - 110A
  • [28] Expression of epidermal growth factor receptor and HER2 in sporadic primary small intestinal adenocarcinoma
    Chen, Z. E.
    Perry, A.
    Lin, F.
    Hui, P.
    Wang, H. L.
    LABORATORY INVESTIGATION, 2007, 87 : 110A - 110A
  • [29] Molecular imaging of human epidermal growth factor receptor 2 (HER-2) expression
    Niu, Gang
    Cai, Weibo
    Chen, Xiaoyuan
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2008, 13 : 790 - 805
  • [30] A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion
    Fichter, Christiane Daniela
    Przypadlo, Camilla Maria
    Buck, Achim
    Herbener, Nicola
    Riedel, Bianca
    Schaefer, Luisa
    Nakagawa, Hiroshi
    Walch, Axel
    Reinheckel, Thomas
    Werner, Martin
    Lassmann, Silke
    JOURNAL OF PATHOLOGY, 2017, 243 (04): : 481 - 495
12345